// App-Quantinova.ai

176 : Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)

Researchers

Presenter

  • Renato Bassan

Principal Investigators

  • Tamara Intermesoli

  • Claudio Romani

  • Agostino Cortelezzi

  • Fabio Ciceri

  • Anna Maria Scattolin

  • Umberto Vitolo

  • Erika Borlenghi

  • Sergio Cortelazzo

  • Andrea Gallamini

  • Lorella Depaoli

  • Leonardo Campiotti

  • Orietta Spinelli

  • Monica Tajana

  • Monica Bocchia

  • Antonella Vitale

  • Marco Ladetto

  • Eros Di Bona

  • Elena Oldani

  • Alessandro Rambaldi

  • Manuela Tosi

  • Chiara Pavoni

  • Ernesta Audisio

  • Giuseppe Rossi

  • Monica Fumagalli

  • Vincenzo Cassibba

  • Daniele Mattei

Medical Centers

  • U.O. di Ematologia e CTMO, Ospedale Oncologico di Riferimento Regionale Armando Businco, Cagliari, Italy

  • Department of Hematology, Ospedale S. Croce e Carle, Cuneo, Italy

  • ASST Ospedale di Cremona, Cremona, Italy

  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

  • Hematology, Ospedale del-Angelo & Ospedale SS. Giovanni e Paolo, Mestre-Venezia, Italy

  • Hematology and Bone Marrow Transplantation Unit, Azienda Ospedaliera Bolzano, Bolzano, Italy

  • Research Innovation and Statistics, Antoine-Lacassagne Cancer Centre, Nice, France

  • Department of Hematology, Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

  • Azienda Ospedaliero, Universitaria Citt della Salute e della Scienza, Torino, Italy

  • Hematology and Bone Marrow Transplant Unit, University of Milan, ASST Papa Giovanni XXIII, Bergamo, Italy

  • Division of Hematology, Ospedale San Gerardo, Monza, Italy

  • Division of Hematology, Udine, Italy

  • Department of Hematology, Spedali Civili di Brescia, Brescia, Italy

  • Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy

  • Dipartimento di Ematologia e Medicina Trasfusionale, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria, Alessandria, Italy

  • Department of Hematology, Ospedale Sclavo, Siena, Siena, Italy

  • Division of Hematology, Department of Oncology and Hematology, AOU Citta della Salute e della Scienza, Turin, Italy

  • Geriatric Unit, Fondazione Ca Granda IRCCS Ospedale Maggiore Policlinico, Milan, Italy

  • Breast Unit- Oncology, Spedali Civili di Brescia, Brescia, Italy

  • Hematology and BMT Unit, IRCCS Ospedale San Raffaele -, Milan, Italy

Locations

  • France

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Hematocrit

  • White Blood Cell

Drug/Treatment

  • Cytarabine liposomal

  • Imatinib

  • IkT001

  • ara-c

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved